Safety and efficacy of the drug in geriatric patients have not been studied specifically to date. Because geriatric patients frequently have decreased renal function (e.g., glomerular filtration), particular attention should be paid to evaluating renal function prior to initiation of loratadine and subsequently thereafter in this age group. If evidence of renal impairment exists or develops, appropriate adjustments in dosage should be made.